238 related articles for article (PubMed ID: 26675666)
1. Cellular peptidyl-prolyl cis/trans isomerase Pin1 facilitates replication of feline coronavirus.
Tanaka Y; Amano A; Morisaki M; Sato Y; Sasaki T
Antiviral Res; 2016 Feb; 126():1-7. PubMed ID: 26675666
[TBL] [Abstract][Full Text] [Related]
2. Feline coronavirus replication is affected by both cyclophilin A and cyclophilin B.
Tanaka Y; Sato Y; Sasaki T
J Gen Virol; 2017 Feb; 98(2):190-200. PubMed ID: 27902373
[TBL] [Abstract][Full Text] [Related]
3. Suppression of feline coronavirus replication in vitro by cyclosporin A.
Tanaka Y; Sato Y; Osawa S; Inoue M; Tanaka S; Sasaki T
Vet Res; 2012 Apr; 43(1):41. PubMed ID: 22546085
[TBL] [Abstract][Full Text] [Related]
4. Dipentamethylene thiuram monosulfide is a novel inhibitor of Pin1.
Tatara Y; Lin YC; Bamba Y; Mori T; Uchida T
Biochem Biophys Res Commun; 2009 Jul; 384(3):394-8. PubMed ID: 19422802
[TBL] [Abstract][Full Text] [Related]
5. Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts.
Göthel SF; Marahiel MA
Cell Mol Life Sci; 1999 Mar; 55(3):423-36. PubMed ID: 10228556
[TBL] [Abstract][Full Text] [Related]
6. The Multiple Roles of Peptidyl Prolyl Isomerases in Brain Cancer.
Stifani S
Biomolecules; 2018 Oct; 8(4):. PubMed ID: 30314361
[TBL] [Abstract][Full Text] [Related]
7. Transduction of hematopoietic stem cells to stimulate RNA interference against feline infectious peritonitis.
Anis EA; Dhar M; Legendre AM; Wilkes RP
J Feline Med Surg; 2017 Jun; 19(6):680-686. PubMed ID: 27354226
[TBL] [Abstract][Full Text] [Related]
8. In vitro inhibition of feline coronavirus replication by small interfering RNAs.
McDonagh P; Sheehy PA; Norris JM
Vet Microbiol; 2011 Jun; 150(3-4):220-9. PubMed ID: 21367541
[TBL] [Abstract][Full Text] [Related]
9. Peptidyl-prolyl cis-trans isomerase NIMA interacting 1 regulates skeletal muscle fusion through structural modification of Smad3 in the linker region.
Islam R; Yoon H; Shin HR; Bae HS; Kim BS; Yoon WJ; Woo KM; Baek JH; Lee YS; Ryoo HM
J Cell Physiol; 2018 Dec; 233(12):9390-9403. PubMed ID: 30132832
[TBL] [Abstract][Full Text] [Related]
10. Effect of small interfering RNAs on in vitro replication and gene expression of feline coronavirus.
Anis EA; Wilkes RP; Kania SA; Legendre AM; Kennedy MA
Am J Vet Res; 2014 Sep; 75(9):828-34. PubMed ID: 25157886
[TBL] [Abstract][Full Text] [Related]
11. Peptidyl-prolyl isomerases: functionality and potential therapeutic targets in cardiovascular disease.
Rostam MA; Piva TJ; Rezaei HB; Kamato D; Little PJ; Zheng W; Osman N
Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):117-24. PubMed ID: 25377120
[TBL] [Abstract][Full Text] [Related]
12. The cholesterol transport inhibitor U18666A inhibits type I feline coronavirus infection.
Takano T; Endoh M; Fukatsu H; Sakurada H; Doki T; Hohdatsu T
Antiviral Res; 2017 Sep; 145():96-102. PubMed ID: 28780424
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterisation of small molecule inhibitors of feline coronavirus replication.
McDonagh P; Sheehy PA; Norris JM
Vet Microbiol; 2014 Dec; 174(3-4):438-447. PubMed ID: 25465182
[TBL] [Abstract][Full Text] [Related]
14. Combination siRNA therapy against feline coronavirus can delay the emergence of antiviral resistance in vitro.
McDonagh P; Sheehy PA; Norris JM
Vet Microbiol; 2015 Mar; 176(1-2):10-8. PubMed ID: 25596968
[TBL] [Abstract][Full Text] [Related]
15. Peptidyl-prolyl isomerase Pin1 is a cellular factor required for hepatitis C virus propagation.
Lim YS; Tran HT; Park SJ; Yim SA; Hwang SB
J Virol; 2011 Sep; 85(17):8777-88. PubMed ID: 21680504
[TBL] [Abstract][Full Text] [Related]
16. An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity.
Ieda N; Itoh K; Inoue Y; Izumiya Y; Kawaguchi M; Miyata N; Nakagawa H
Bioorg Med Chem Lett; 2019 Feb; 29(3):353-356. PubMed ID: 30585173
[TBL] [Abstract][Full Text] [Related]
17. The peptidyl-prolyl cis/trans isomerase Pin1 interacts with three early regulatory proteins of human cytomegalovirus.
Schütz M; Thomas M; Wangen C; Wagner S; Rauschert L; Errerd T; Kießling M; Sticht H; Milbradt J; Marschall M
Virus Res; 2020 Aug; 285():198023. PubMed ID: 32428517
[TBL] [Abstract][Full Text] [Related]
18. Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity--targets--functions.
Galat A
Curr Top Med Chem; 2003; 3(12):1315-47. PubMed ID: 12871165
[TBL] [Abstract][Full Text] [Related]
19. Effects of immunophilin inhibitors and non-immunosuppressive analogs on coronavirus replication in human infection models.
Berthold EJ; Ma-Lauer Y; Chakraborty A; von Brunn B; Hilgendorff A; Hatz R; Behr J; Hausch F; Staab-Weijnitz CA; von Brunn A
Front Cell Infect Microbiol; 2022; 12():958634. PubMed ID: 36211973
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of enzyme activities and mRNA levels of peptidyl prolyl cis/trans isomerases in various organs of wild type and Pin1-/- mice.
Fanghänel J; Akiyama H; Uchida C; Uchida T
FEBS Lett; 2006 May; 580(13):3237-45. PubMed ID: 16697379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
